These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11982685)

  • 1. Tolterodine: a safe and effective treatment for older patients with overactive bladder.
    Kausar SA
    J Am Geriatr Soc; 2002 Apr; 50(4):775. PubMed ID: 11982685
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolterodine once-daily in treatment of the overactive bladder.
    Peters KM; Huang RR
    Urology; 2001 Nov; 58(5):829-32. PubMed ID: 11711378
    [No Abstract]   [Full Text] [Related]  

  • 3. Review. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine.
    Kobelt G; Kirchberger I; Malone-Lee J
    BJU Int; 1999 Apr; 83(6):583-90. PubMed ID: 10233562
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of the overactive bladder with tolterodine, a new muscarinic receptor antagonist.
    Messelink EJ
    BJU Int; 1999 Mar; 83 Suppl 2():48-52. PubMed ID: 10210605
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of overactive bladder: the Antimuscarinic Clinical Effectiveness Trial.
    Appell RA
    Curr Urol Rep; 2002 Oct; 3(5):343-4. PubMed ID: 12354340
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experiences with tolterodine.
    Nilvebrant L
    Life Sci; 2001 Apr; 68(22-23):2549-56. PubMed ID: 11392625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolterodine for overactive bladder.
    Med Lett Drugs Ther; 1998 Oct; 40(1038):101-2. PubMed ID: 9813595
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic treatment for detrusor overactivity.
    Lai HH; Boone TB; Appell RA
    Curr Urol Rep; 2002 Oct; 3(5):365-72. PubMed ID: 12354344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients.
    Zinner NR; Mattiasson A; Stanton SL
    J Am Geriatr Soc; 2002 May; 50(5):799-807. PubMed ID: 12028164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of the overactive bladder with detrusitol].
    Golomb J
    Harefuah; 2000 Dec; 139(11-12):467-70. PubMed ID: 11341197
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolterodine use for symptoms of overactive bladder.
    Ruscin JM; Morgenstern NE
    Ann Pharmacother; 1999 Oct; 33(10):1073-82. PubMed ID: 10534221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexible dose fesoterodine in the treatment of overactive bladder (OAB).
    Tubaro A; De Nunzio C
    BJU Int; 2013 Aug; 112(3):281-2. PubMed ID: 23826839
    [No Abstract]   [Full Text] [Related]  

  • 13. Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.
    Abrams P; Malone-Lee J; Jacquetin B; Wyndaele JJ; Tammela T; Jonas U; Wein A
    Drugs Aging; 2001; 18(7):551-60. PubMed ID: 11482747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of efficacy and tolerability of tolterodine in children with overactive bladder.
    Raes A; Hoebeke P; Segaert I; Van Laecke E; Dehoorne J; Vande Walle J
    Eur Urol; 2004 Feb; 45(2):240-4. PubMed ID: 14734013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder.
    Jacquetin B; Wyndaele J
    Eur J Obstet Gynecol Reprod Biol; 2001 Sep; 98(1):97-102. PubMed ID: 11516807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of new treatments for overactive bladder: the example of tolterodine, a new muscarinic agent: a Markov model.
    Kobelt G; Jönsson L; Mattiasson A
    Neurourol Urodyn; 1998; 17(6):599-611. PubMed ID: 9829424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolterodine: an overview.
    Wefer J; Truss MC; Jonas U
    World J Urol; 2001 Nov; 19(5):312-8. PubMed ID: 11760779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity--a comment.
    Short DD
    Pharmacotherapy; 1999 Oct; 19(10):1188. PubMed ID: 10512072
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for the efficacy and safety of tolterodine in the treatment of overactive bladder.
    Abrams P
    Expert Opin Pharmacother; 2001 Oct; 2(10):1685-701. PubMed ID: 11825311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolterodine for the treatment of overactive bladder: a review.
    Rovner ES
    Expert Opin Pharmacother; 2005 Apr; 6(4):653-66. PubMed ID: 15934891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.